As a consequence, the therapeutic inhibition of COX-2, PGE2, and/or their receptors—prostaglandin E receptor 2 (PTGER2) and prostaglandin E receptor 4 (PTGER4)—decreases the survival and invasive ability of endometriosis cells [22]. The gene discussed is PTGER4; the disease is endometriosis.